Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-11-29FDA Approved: CEFAZOLIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Cefazolin (cefazolin sodium) from Fresenius Kabi USA, LLC, updating an already approved prod…
-
FDA approval · 2010-10-21FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)
FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) [Phase 4]
Phase 4 randomized trial comparing tigecycline to ceftriaxone plus metronidazole in complicated intra-abdominal infection; study completed w…
-
FDA approval · 2010-03-12FDA Approved: CEFOXITIN — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved an original ANDA for cefoxitin by Hikma Pharmaceuticals USA, enabling a generic version of cefoxitin for its indicated infe…
-
FDA approval · 2009-12-22FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma's Ampicillin and Sulbactam as an Original Application (AND A065406), a generic antibiotic combining ampicillin with sulba…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-01Clinical Trial Update: Study Evaluating the Etiology of Intra-Abdominal Infections
The trial evaluating the etiology of intra-abdominal infections has completed; sponsor Wyeth is now a subsidiary of Pfizer.
-
FDA approval · 2009-06-23FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic Metronidazole product.
-
FDA approval · 2009-06-18FDA Approved: CEFTRIAXONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for ceftriaxone sodium (ceftriaxone) from Baxter Healthcare Company, authorizing changes to the appr…
-
FDA approval · 2009-06-12FDA Approved: CEFOXITIN — Original Application (WG Critical Care, LLC)
FDA approves Cefoxitin (cefoxitin) under an original application from WG Critical Care, LLC.
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection [Phase 4]
A Phase 4 randomized trial comparing tigecycline to ceftriaxone plus metronidazole for complicated intra-abdominal infection has completed a…
-
CLINICAL_TRIALS research · 2009-03-12Clinical Trial Update: Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
This document provides an update on a clinical trial studying antibiotic-resistant bacteria in patients with severe intra-abdominal infectio…
-
CLINICAL_TRIALS trial_result · 2008-12-02Clinical Trial Update: A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections [Phase 4]
A Phase IV trial evaluating Magnex (cefoperazone-sulbactam) for intra-abdominal infection has completed, with the document serving as a stat…
-
FDA approval · 2007-12-19FDA Approved: METRONIDAZOLE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original Abbreviated New Drug Application for metronidazole, enabling a generic version of this antimi…
-
FDA approval · 2007-11-09FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s generic amoxicillin and clavulanate potassium under an Original Application.
-
FDA approval · 2007-10-31FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Hospira, Inc)
FDA approved a supplemental application for ampicillin/sulbactam from Hospira for the existing product (Unasyn).
-
FDA approval · 2007-06-27FDA Approved: METRONIDAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Metronidazole from Chartwell RX, LLC (ANDA number 076522).